Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deuschle

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
QRB. Quality Review Bulletin|November 1, 1976
Quality assurance program of a prepaid group practice planD N Logsdon, J M Deuschle, A Varela
Pharmacopsychiatry|March 4, 2008
Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatmentR Hellweg, A Ziegenhorn, I Heuser, et al.
Der Nervenarzt|January 26, 2011
[Epigenetic mechanisms in major depression]G Paslakis, S Bleich, H Frieling, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Major depression and impaired glucose toleranceB Weber, U Schweiger, M Deuschle, et al.
The American Journal of Psychiatry|January 5, 2000
Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-upU Schweiger, B Weber, M Deuschle, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
[Dysfunction of the hypothalamus-pituitary-adrenal system--background variable of relevant cardiovascular risk factors?--description of a cooperative project]F Lederbogen, M Deuschle Für Die Kora-Studiengruppe
Pharmacopsychiatry|July 21, 2015
Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF)M Deuschle, M Gilles, B Scharnholz, et al.
Pharmacopsychiatry|December 17, 2009
Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case seriesG Paslakis, M Gilles, A Meyer-Lindenberg, et al.
Psychopharmacology|May 1, 1997
Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patientsM Deuschle, S Härtter, C Hiemke, et al.
Biological Psychiatry|August 6, 1999
A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutismJ Schmider, H Standhart, M Deuschle, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
QRB. Quality Review Bulletin|November 1, 1976
Quality assurance program of a prepaid group practice planD N Logsdon, J M Deuschle, A Varela
Pharmacopsychiatry|March 4, 2008
Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatmentR Hellweg, A Ziegenhorn, I Heuser, et al.
Der Nervenarzt|January 26, 2011
[Epigenetic mechanisms in major depression]G Paslakis, S Bleich, H Frieling, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Major depression and impaired glucose toleranceB Weber, U Schweiger, M Deuschle, et al.
The American Journal of Psychiatry|January 5, 2000
Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-upU Schweiger, B Weber, M Deuschle, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
[Dysfunction of the hypothalamus-pituitary-adrenal system--background variable of relevant cardiovascular risk factors?--description of a cooperative project]F Lederbogen, M Deuschle Für Die Kora-Studiengruppe
Pharmacopsychiatry|July 21, 2015
Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF)M Deuschle, M Gilles, B Scharnholz, et al.
Pharmacopsychiatry|December 17, 2009
Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case seriesG Paslakis, M Gilles, A Meyer-Lindenberg, et al.
Psychopharmacology|May 1, 1997
Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patientsM Deuschle, S Härtter, C Hiemke, et al.
Biological Psychiatry|August 6, 1999
A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutismJ Schmider, H Standhart, M Deuschle, et al.
Pageof 9